ESR1 and osteoporosis: The distribution of osteoporosis medications used was as follows: vitamin D preparations in 15 cases (42%), bisphosphonates in 11 cases (31%), selective estrogen receptor modulators in 7 cases (19%), denosumab in 2 cases (5%), and teriparatide in 1 case (3%) (Figure 1).